Missense mutations in disease genes: a Bayesian approach to evaluate causality.
about
Two-phase and family-based designs for next-generation sequencing studiesClassification of Missense Mutations of Disease GenesThe implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experienceA full-likelihood method for the evaluation of causality of sequence variants from family data.Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genesIntegrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2Understanding missense mutations in the BRCA1 gene: an evolutionary approach.Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.Identification of rare causal variants in sequence-based studies: methods and applications to VPS13B, a gene involved in Cohen syndrome and autismInterpretation of genetic association studies in complex disease.Two-stage family-based designs for sequencing studies.A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genesSerbian high-risk families: extensive results on BRCA mutation spectra and frequency.Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.Bayesian oligogenic analysis of quantitative and qualitative traits in general pedigrees.
P2860
Q26828744-3101A0FE-D610-4DBB-B52A-C88BE77CD5EFQ28383958-BAD627EE-A498-4989-B447-8A6B1FDE465DQ30590291-D4DFBACB-B97B-4DB4-B9F8-FDD2AEFB7D36Q30816468-A21BA009-5CF9-4666-85CF-DA56BC6F7356Q33379396-9E7F15C0-9CBE-47BF-A5CC-C00E56A59722Q33475933-3094BA10-3BE9-480F-8D43-8881998DA540Q33779382-40C5CAA5-8F54-4ABF-814C-443260756306Q33910123-8692AF8F-27F2-40EC-92B5-90915F53418CQ34329529-B2FDFD0A-A1D7-4028-8512-452F9EDAE785Q34388778-70858D6B-091C-44EB-9CB9-BBE9D8EC58D9Q34682335-A0D1D2A8-FF7D-40E2-B298-1544865A399BQ35082735-51C36D85-C0C8-4CC7-9896-F98B58FB3285Q35527971-47CE1B20-FDC5-4623-A635-9BCED836E2A1Q36492194-1C4968BA-8B35-4016-973C-25DA67A9C651Q46055330-9DA7EC05-9AA8-47AC-A532-67FC198E5376Q51966307-3F64AF35-47E9-42E4-BF28-B05725E2935EQ52053068-2D80BC8B-15A2-44A1-AE15-AA85002E40E6
P2860
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@ast
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@en
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@nl
type
label
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@ast
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@en
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@nl
prefLabel
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@ast
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@en
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@nl
P2093
P2860
P356
P1476
Missense mutations in disease genes: a Bayesian approach to evaluate causality.
@en
P2093
G M Petersen
G Parmigiani
P2860
P304
P356
10.1086/301871
P407
P577
1998-06-01T00:00:00Z